Chemorefractory Gastric Cancer: The Evolving Terrain of Third-Line Therapy and Beyond.

Cancers (Basel) · 2022 · PMC8945913 · PMID 35326560

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Indeed, a positive trend toward a better QoL was observed within patients receiving trifluridine/tipiracil [ 46 ].

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.